trending Market Intelligence /marketintelligence/en/news-insights/trending/Jyd_4JmnjT_TvZf4hW0l7w2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

BioPharmX adds board member


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

BioPharmX adds board member

BioPharmX Corp.'s board elected Charles Vontz as an independent board member, effective Jan. 17.

Vontz was most recently the president and CEO of Topica Pharmaceuticals.

The company's board now comprises four directors, three of whom are independent.